Services
Premier services that lead to better, faster decisions, customized solutions, and successful partnerships.
Premier services that lead to better, faster decisions, customized solutions, and successful partnerships.
In-house and commercially-available data to meet your needs.
Over 1000 peer-reviewed publications in dozens of therapeutic areas!
Exp Rev Hematol
Escobar M, Bullano M, Mokdad AG, et al. A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors. Exp Rev Hematol. 2023 Apr 28;1-8.
Get the latest news, highlights and more about conferences, RWD, and evidence generation from The Authority in RWE.